Experimental Pemvidutide Cut 1.45 More Heavy Drinking Days a Week Than Placebo in a 100-Person Alcohol Trial
An experimental weekly injection from Altimmune reduced heavy drinking days more than placebo in a small 24-week trial, though side effects were common and results remain unpublished in a peer-reviewed journal.
Medical Daily ·